Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top

Puma biotechnology press release top

Puma biotechnology press release top, Puma Biotechnology Inc CEO Alan Auerbach Sells 41 396 Shares top

$54.00

SKU: 7491388

Colour
  • Puma Biotech starts phase II trial for lung cancer therapy By Investing
  • Puma biotechnology press hot sale release
  • Puma Biotechnology announces presentation of findings from a phase II study of alisertib in endocrine resistant metastatic breast cancer Express Pharma
  • The Future of Medicine Key Biotech Stocks to Watch OSTX CRBP
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus